PharmEasy's rights issue cements one of the steepest markdowns in Indian unicorn history
API Holdings' rights issue in early 2024, priced at a level that implies a valuation of roughly three hundred million dollars or less depending on the conversion assumptions, formalises a markdown from the company's Series F peak of approximately five and a half billion dollars that is among the mos
Source: Mint Street